Satralizumab manufacturers
- Satralizumab
-
- $128.00
-
2026-08-08
- CAS:1535963-91-7
- Purity: 95.00%
- Supply Ability: 10g
|
| | Satralizumab Basic information |
| Product Name: | Satralizumab | | Synonyms: | Research Grade Satralizumab(DHC36904);Research Grade Satralizumab;Satralizumab | | CAS: | 1535963-91-7 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Satralizumab Structure]() |
| | Satralizumab Chemical Properties |
| storage temp. | Store at -20°C | | form | Liquid | | color | Colorless to light yellow |
| | Satralizumab Usage And Synthesis |
| Uses | Sapelizumab is a CHO-expressed humanized antibody targeting IL-6Ra/CD126. Sapelizumab has a huIgG2 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Sapelizumab can refer to Human IgG2 kappa, Isotype Control (HY-P99002). |
| | Satralizumab Preparation Products And Raw materials |
|